Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Net Income (2022 - 2025)

Bioregenx (BRGX) has 4 years of Net Income data on record, last reported at -$80565.0 in Q3 2025.

  • For Q3 2025, Net Income rose 79.6% year-over-year to -$80565.0; the TTM value through Sep 2025 reached -$18.9 million, down 294.89%, while the annual FY2024 figure was -$23.1 million, 3216.31% down from the prior year.
  • Net Income reached -$80565.0 in Q3 2025 per BRGX's latest filing, up from -$178345.0 in the prior quarter.
  • Across five years, Net Income topped out at -$2191.0 in Q3 2022 and bottomed at -$18.4 million in Q4 2024.
  • Average Net Income over 4 years is -$1.6 million, with a median of -$139319.0 recorded in 2023.
  • Peak YoY movement for Net Income: crashed 26695.74% in 2024, then soared 91.54% in 2025.
  • A 4-year view of Net Income shows it stood at -$5535.0 in 2022, then plummeted by 2417.06% to -$139319.0 in 2023, then crashed by 13107.51% to -$18.4 million in 2024, then skyrocketed by 99.56% to -$80565.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income were -$80565.0 in Q3 2025, -$178345.0 in Q2 2025, and -$266854.0 in Q1 2025.